Larvol Delta - Celltrionannounced-the-launch-of-the-300-mg-strength-of-Omlyclo-omalizumab-a-treatment-for-chronic-spontaneous-urticaria-and-allergic-asthma-in-Europe

Omlyclo (omalizumab-igec) - Celltrion

https://www.businesswire.com/news/home/20260824054400/en/Celltrion-Expands-Omlyclo-Portfolio-in-Europe-with-Launch-of-300-mg-Strength

Aug 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next